TB-500 (Thymosin Beta-4)

What it is?

TB-500 is a synthetic form associated with Thymosin Beta-4 activity, studied for its role in tissue repair signalling and inflammation balance. It is commonly positioned for protocols targeting recovery, mobility restoration, and connective tissue resilience.

Dripfy Advantage

• Regeneration signalling: Supports repair pathways linked to tissue remodelling and recovery following mechanical stress.
• Angiogenesis support: Associated with vascular signalling that can support oxygen and nutrient delivery to recovering tissue.
• Cell migration dynamics: Studied for its role in cell migration and tissue re-organisation during repair processes.
• Inflammation modulation: May influence inflammatory signalling balance, supporting recovery environments without prolonged inflammatory load.
• Oxidative stress interface: Frequently positioned in protocols where oxidative stress markers are relevant during tissue recovery cycles.

Clinical Applications & Therapeutic Potential

• Connective tissue recovery: Positioned for tendon and ligament recovery endpoints and joint resilience signalling in musculoskeletal models.
• Post-injury mobility outcomes: Potential support for flexibility and range-of-motion recovery through tissue remodelling dynamics.
• Inflammation and discomfort pathways: Potential reduction in inflammation-associated markers and improved recovery comfort endpoints.
• Training recovery protocols: Often included in performance settings to support faster recovery kinetics after intense load.

Composition & Formulation

• Peptide content: 5 mg TB-500
• Vehicle: Proprietary pH-balanced buffer solution
• Delivery system: Pre-filled, multi-dose, closed-system pen
• Total volume: 3 mL
• Purity: ≥99% by HPLC/MS